Vaxcell-Bio Therapeutics Logo

Vaxcell-Bio Therapeutics

Biotech firm developing immunotherapies for oncology and other diseases.

323990 | KO

Overview

Corporate Details

ISIN(s):
KR7323990002
LEI:
Country:
South Korea
Address:
전라남도 화순군 화순읍 산단길 12-55, 화순군

Description

Vaxcell-Bio Therapeutics is a biotechnology company specializing in the research and development of innovative immunotherapies. The company's primary focus is on oncology, developing a pipeline of cell-based and protein-based treatments, including immune cell therapies and targeted protein-degrading therapeutics. In addition to its core focus on cancer, Vaxcell-Bio is expanding its research into other areas, such as developing drug delivery system (DDS)-based therapies for conditions like macular degeneration.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2021-05-17 00:00
분기보고서 (2021.03)
Korean HTML 831.0 KB
2021-04-15 00:00
주식매수선택권부여에관한신고
Korean HTML 12.4 KB
2021-04-05 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 134.2 KB
2021-04-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 23.6 KB
2021-03-29 00:00
주식매수선택권행사
Korean HTML 20.1 KB
2021-03-25 00:00
정기주주총회결과
Korean HTML 19.2 KB
2021-03-25 00:00
주식매수선택권부여에관한신고
Korean HTML 12.4 KB
2021-03-17 00:00
감사보고서제출
Korean HTML 17.5 KB
2021-03-17 00:00
사업보고서 (2020.12)
Korean HTML 886.6 KB
2021-03-10 00:00
주주총회소집공고
Korean HTML 166.0 KB
2021-03-09 00:00
주주총회소집결의
Korean HTML 8.6 KB
2021-03-08 00:00
기타경영사항(특허권취득)(자율공시)(OX40L을 발현하는 배양보조세포 및 이를 이용한 자연살해세포 배양 방법)
Korean HTML 6.6 KB
2021-02-09 00:00
대표이사변경
Korean HTML 13.6 KB
2021-02-09 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean HTML 11.4 KB
2020-12-18 00:00
기업설명회(IR)개최
Korean HTML 7.0 KB

Automate Your Workflow. Get a real-time feed of all Vaxcell-Bio Therapeutics filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vaxcell-Bio Therapeutics

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vaxcell-Bio Therapeutics via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.